Device Trial Radar · NCT03579212
Evaluation of the Performance of Y-STRUT® Medical Device to Strengthen Pre-fractural Tumour-induced Lesions at the Level of the Proximal Femur
Last checked: Nov 20, 2026Latest source record: Apr 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
16
Actual
Start
Nov 2016
Primary completion
Feb 28, 2021
Study completion Feb 28, 2021
Sponsor
- Lead sponsor
- HypreventionNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 6, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
HIPPON 100 is a national, multicentre, prospective, retrospective, descriptive and non-interventional study, in patients having a Y-STRUT® medical device implanted to prevent a high risk of impending pathological fracture. The primary objective of this study is to evaluate the performance of the studied medical device by measuring the frequency of patient with a fracture at the implantation site within 1 year after implantation. A total of 100 patients from France will be enrolled (until November 2018) and followed up to 24 months.
Conditions
- Pathological Fracture of Hip
- Bone Metastases
Interventions
Y-STRUT® (Hyprevention, Pessac, France)Device
The studied medical device consists of two components implanted in the proximal femur, combined with bone cement.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of post-operative fracture [Performance of the device]Time frame: At 12 months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
CHU Caen
Caen, France
Hôpital européen Georges-Pompidou
Paris, France
Hopital Tenon - AP-HP
Paris, France
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.